Lotus Bio Technology Development Stock Total Debt
| LBTD Stock | USD 0.01 0.00 0.00% |
Lotus Bio Technology Development fundamentals help investors to digest information that contributes to Lotus Bio's financial success or failures. It also enables traders to predict the movement of Lotus Pink Sheet. The fundamental analysis module provides a way to measure Lotus Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lotus Bio pink sheet.
Lotus |
Lotus Bio Technology Development Company Total Debt Analysis
Lotus Bio's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Lotus Bio Total Debt | 16.68 K |
Most of Lotus Bio's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lotus Bio Technology Development is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Lotus Bio Technology Development has a Total Debt of 16.68 K. This is 100.0% lower than that of the Media (discontinued effective close of September 28, 2018) sector and 100.0% lower than that of the Consumer Discretionary industry. The total debt for all United States stocks is 100.0% higher than that of the company.
Lotus Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lotus Bio's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Lotus Bio could also be used in its relative valuation, which is a method of valuing Lotus Bio by comparing valuation metrics of similar companies.Lotus Bio is currently under evaluation in total debt category among its peers.
Lotus Fundamentals
| Return On Asset | -4.21 | |||
| Current Valuation | 31.31 M | |||
| Shares Outstanding | 782.77 M | |||
| Shares Owned By Insiders | 60.40 % | |||
| Price To Earning | (1.71) X | |||
| Net Income | (19.55 K) | |||
| Cash And Equivalents | 1 | |||
| Total Debt | 16.68 K | |||
| Cash Flow From Operations | (17.75 K) | |||
| Beta | -1.44 | |||
| Market Capitalization | 13.78 M | |||
| Total Asset | 5.46 K | |||
| Retained Earnings | (931 K) | |||
| Working Capital | (68 K) | |||
| Current Liabilities | 68 K | |||
| Net Asset | 5.46 K |
About Lotus Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lotus Bio Technology Development's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Bio Technology Development based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Lotus Pink Sheet
Lotus Bio financial ratios help investors to determine whether Lotus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lotus with respect to the benefits of owning Lotus Bio security.